| James Mu, MD | |
|
4225 Hoyt Ave, Suite A, Everett, WA 98203-2351 | |
| (425) 259-3122 | |
| Not Available |
| Full Name | James Mu |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 40 Years |
| Location | 4225 Hoyt Ave, Everett, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841231438 | NPI | - | NPPES |
| 8256059 | Medicaid | WA | |
| 0140320 | Other | WA | LABOR AND INDUSTRY |
| MD00038720 | Other | WA | STATE LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD00038720 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Regional Medical Center Everett | Everett, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Western Washington Medical Group Inc Ps | 7517870314 | 101 |
News Archive
Researchers from Lomonosov MSU Faculty of Biology have studied the stages of entosis, a process of cell death when one cell invades the other and gets digested inside of it. Entosis could become a new method of destroying cancer cells.
Pharmaceutical companies in the Asia Pacific region are increasingly adapting their business models from the production of generic drugs towards more high-risk, high-return research and development, according to a new report released today by CMR International, a Thomson Reuters business.
It was November 2014, and I was working on a feature story about a buzzed-about blood-testing company in Silicon Valley that promised to "disrupt" the lab industry with new technology.
Thousands of vulnerable patients could be taking ground-breaking COVID-19 antivirals this winter after the government announced deals to secure two new treatments.
The COVID-19 vaccine candidate (KBP-COVID-19; NCT04473690) will become one of a number of potential vaccines to have progressed beyond pre-clinical testing.
› Verified 6 days ago
| Entity Name | Western Washington Medical Group Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396413803 PECOS PAC ID: 7517870314 Enrollment ID: O20031107000469 |
News Archive
Researchers from Lomonosov MSU Faculty of Biology have studied the stages of entosis, a process of cell death when one cell invades the other and gets digested inside of it. Entosis could become a new method of destroying cancer cells.
Pharmaceutical companies in the Asia Pacific region are increasingly adapting their business models from the production of generic drugs towards more high-risk, high-return research and development, according to a new report released today by CMR International, a Thomson Reuters business.
It was November 2014, and I was working on a feature story about a buzzed-about blood-testing company in Silicon Valley that promised to "disrupt" the lab industry with new technology.
Thousands of vulnerable patients could be taking ground-breaking COVID-19 antivirals this winter after the government announced deals to secure two new treatments.
The COVID-19 vaccine candidate (KBP-COVID-19; NCT04473690) will become one of a number of potential vaccines to have progressed beyond pre-clinical testing.
› Verified 6 days ago
| Entity Name | Public Hospital District 1 Of Snohomish County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013074061 PECOS PAC ID: 3274426259 Enrollment ID: O20040204000272 |
News Archive
Researchers from Lomonosov MSU Faculty of Biology have studied the stages of entosis, a process of cell death when one cell invades the other and gets digested inside of it. Entosis could become a new method of destroying cancer cells.
Pharmaceutical companies in the Asia Pacific region are increasingly adapting their business models from the production of generic drugs towards more high-risk, high-return research and development, according to a new report released today by CMR International, a Thomson Reuters business.
It was November 2014, and I was working on a feature story about a buzzed-about blood-testing company in Silicon Valley that promised to "disrupt" the lab industry with new technology.
Thousands of vulnerable patients could be taking ground-breaking COVID-19 antivirals this winter after the government announced deals to secure two new treatments.
The COVID-19 vaccine candidate (KBP-COVID-19; NCT04473690) will become one of a number of potential vaccines to have progressed beyond pre-clinical testing.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Mu, MD 4225 Hoyt Ave, Suite A, Everett, WA 98203-2351 Ph: (425) 259-3122 | James Mu, MD 4225 Hoyt Ave, Suite A, Everett, WA 98203-2351 Ph: (425) 259-3122 |
News Archive
Researchers from Lomonosov MSU Faculty of Biology have studied the stages of entosis, a process of cell death when one cell invades the other and gets digested inside of it. Entosis could become a new method of destroying cancer cells.
Pharmaceutical companies in the Asia Pacific region are increasingly adapting their business models from the production of generic drugs towards more high-risk, high-return research and development, according to a new report released today by CMR International, a Thomson Reuters business.
It was November 2014, and I was working on a feature story about a buzzed-about blood-testing company in Silicon Valley that promised to "disrupt" the lab industry with new technology.
Thousands of vulnerable patients could be taking ground-breaking COVID-19 antivirals this winter after the government announced deals to secure two new treatments.
The COVID-19 vaccine candidate (KBP-COVID-19; NCT04473690) will become one of a number of potential vaccines to have progressed beyond pre-clinical testing.
› Verified 6 days ago
Timothy Edward Mcnamara, Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1001 N Broadway, Suite A3, Everett, WA 98201 Phone: 425-317-0300 Fax: 425-317-0303 | |
Dr. Madhurina Roy, M.D Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9505 19th Ave Se, Ste 100, Everett, WA 98208 Phone: 425-225-6721 Fax: 425-225-6725 | |
Dr. Kavyashri Kodlipet Jagadeesh, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1330 Rockefeller Ave Ste 210, Everett, WA 98201 Phone: 425-261-4940 Fax: 425-261-4932 | |
Amy D Nelson, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2930 Maple St, Everett, WA 98201 Phone: 425-261-1500 Fax: 425-261-1515 | |
Ya-lan Huang, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1330 Rockefeller Ave, Suite 450, Everett, WA 98201 Phone: 425-258-6801 | |
Mahesh Mulumudi, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3901 Hoyt Ave, Everett, WA 98201 Phone: 425-339-5411 | |
James M Schmitt, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 12728 19th Ave Se, Suite 200, Everett, WA 98208 Phone: 425-225-2700 Fax: 425-225-2790 |